Concepts (131)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Procrastination | 1 | 2022 | 1 | 0.820 |
Why?
|
| Sleep Deprivation | 1 | 2022 | 50 | 0.780 |
Why?
|
| Sleep | 1 | 2022 | 339 | 0.650 |
Why?
|
| Asthma | 4 | 2013 | 749 | 0.510 |
Why?
|
| Patient Admission | 4 | 2023 | 185 | 0.480 |
Why?
|
| Bronchiolitis, Viral | 3 | 2011 | 30 | 0.470 |
Why?
|
| Hypotonic Solutions | 1 | 2014 | 15 | 0.450 |
Why?
|
| Respiratory Syncytial Virus Infections | 5 | 2011 | 342 | 0.450 |
Why?
|
| Isotonic Solutions | 1 | 2014 | 35 | 0.450 |
Why?
|
| Child, Hospitalized | 1 | 2014 | 71 | 0.430 |
Why?
|
| Fluid Therapy | 1 | 2014 | 125 | 0.420 |
Why?
|
| Hyponatremia | 1 | 2014 | 72 | 0.410 |
Why?
|
| Triage | 3 | 2023 | 137 | 0.350 |
Why?
|
| Apnea | 1 | 2009 | 31 | 0.320 |
Why?
|
| Intensive Care Units, Pediatric | 3 | 2019 | 481 | 0.270 |
Why?
|
| Critical Care | 3 | 2022 | 656 | 0.250 |
Why?
|
| Patient Discharge | 2 | 2019 | 488 | 0.250 |
Why?
|
| Albinism, Oculocutaneous | 1 | 2004 | 1 | 0.240 |
Why?
|
| Nystagmus, Congenital | 1 | 2004 | 1 | 0.240 |
Why?
|
| Bronchiolitis | 3 | 2015 | 119 | 0.240 |
Why?
|
| Oculomotor Muscles | 1 | 2004 | 64 | 0.230 |
Why?
|
| Hospitalization | 5 | 2023 | 1770 | 0.220 |
Why?
|
| Infant, Premature | 1 | 2009 | 812 | 0.220 |
Why?
|
| Pneumonia | 2 | 2018 | 323 | 0.200 |
Why?
|
| Hospitalists | 1 | 2022 | 45 | 0.190 |
Why?
|
| Pediatrics | 2 | 2022 | 1159 | 0.190 |
Why?
|
| Hospitals | 1 | 2023 | 389 | 0.170 |
Why?
|
| Length of Stay | 2 | 2015 | 1307 | 0.160 |
Why?
|
| Child | 12 | 2023 | 24363 | 0.150 |
Why?
|
| Community-Acquired Infections | 2 | 2018 | 240 | 0.130 |
Why?
|
| Continuity of Patient Care | 1 | 2018 | 151 | 0.130 |
Why?
|
| Humans | 21 | 2023 | 124257 | 0.120 |
Why?
|
| Bacterial Typing Techniques | 1 | 2015 | 102 | 0.120 |
Why?
|
| Infant | 10 | 2019 | 12465 | 0.110 |
Why?
|
| Severity of Illness Index | 4 | 2013 | 2883 | 0.110 |
Why?
|
| Oximetry | 1 | 2015 | 162 | 0.110 |
Why?
|
| Monitoring, Physiologic | 1 | 2015 | 356 | 0.110 |
Why?
|
| Mycoplasma pneumoniae | 1 | 2013 | 12 | 0.100 |
Why?
|
| Nebulizers and Vaporizers | 2 | 2010 | 57 | 0.100 |
Why?
|
| United States | 5 | 2023 | 10874 | 0.100 |
Why?
|
| Attitude of Health Personnel | 1 | 2018 | 662 | 0.100 |
Why?
|
| Infusions, Intravenous | 1 | 2014 | 547 | 0.100 |
Why?
|
| Child, Preschool | 7 | 2018 | 13997 | 0.100 |
Why?
|
| Risk Assessment | 2 | 2014 | 3429 | 0.100 |
Why?
|
| Bacterial Toxins | 1 | 2013 | 175 | 0.100 |
Why?
|
| Risk | 1 | 2014 | 754 | 0.100 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2018 | 728 | 0.090 |
Why?
|
| Health Status | 1 | 2013 | 371 | 0.090 |
Why?
|
| Cohort Studies | 4 | 2018 | 4779 | 0.090 |
Why?
|
| Saline Solution, Hypertonic | 1 | 2010 | 19 | 0.090 |
Why?
|
| Vocal Cords | 1 | 2009 | 65 | 0.080 |
Why?
|
| Forced Expiratory Volume | 1 | 2009 | 171 | 0.080 |
Why?
|
| Cough | 1 | 2009 | 87 | 0.080 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2009 | 76 | 0.080 |
Why?
|
| Environment | 1 | 2009 | 144 | 0.080 |
Why?
|
| Bacterial Infections | 1 | 2011 | 310 | 0.080 |
Why?
|
| Delphi Technique | 2 | 2019 | 211 | 0.070 |
Why?
|
| Anti-Asthmatic Agents | 1 | 2009 | 112 | 0.070 |
Why?
|
| Cost of Illness | 1 | 2009 | 245 | 0.070 |
Why?
|
| Bacterial Proteins | 1 | 2013 | 889 | 0.070 |
Why?
|
| Allergens | 1 | 2009 | 252 | 0.070 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2009 | 317 | 0.070 |
Why?
|
| Environmental Exposure | 1 | 2009 | 221 | 0.070 |
Why?
|
| Quality of Life | 2 | 2013 | 1899 | 0.070 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2009 | 314 | 0.070 |
Why?
|
| Adolescent | 6 | 2023 | 19253 | 0.060 |
Why?
|
| Anti-Bacterial Agents | 1 | 2018 | 2427 | 0.060 |
Why?
|
| Combined Modality Therapy | 1 | 2009 | 1228 | 0.060 |
Why?
|
| Physician-Patient Relations | 1 | 2009 | 429 | 0.060 |
Why?
|
| Macrophage Inflammatory Proteins | 2 | 2005 | 12 | 0.060 |
Why?
|
| Survival Analysis | 1 | 2009 | 1491 | 0.060 |
Why?
|
| Head Movements | 1 | 2004 | 24 | 0.060 |
Why?
|
| Eye Movements | 1 | 2004 | 69 | 0.060 |
Why?
|
| Posture | 1 | 2004 | 138 | 0.060 |
Why?
|
| Electrophysiology | 1 | 2004 | 271 | 0.060 |
Why?
|
| Interleukin-18 | 1 | 2004 | 60 | 0.060 |
Why?
|
| Ophthalmologic Surgical Procedures | 1 | 2004 | 87 | 0.060 |
Why?
|
| Diagnosis, Differential | 1 | 2009 | 1881 | 0.050 |
Why?
|
| Interleukin-12 | 1 | 2004 | 114 | 0.050 |
Why?
|
| Male | 10 | 2018 | 61033 | 0.050 |
Why?
|
| Infant, Newborn | 4 | 2011 | 8189 | 0.050 |
Why?
|
| Emergency Service, Hospital | 2 | 2023 | 1085 | 0.050 |
Why?
|
| Patient Acuity | 1 | 2023 | 65 | 0.050 |
Why?
|
| Prevalence | 1 | 2009 | 2445 | 0.050 |
Why?
|
| Female | 10 | 2018 | 66312 | 0.050 |
Why?
|
| Syndrome | 1 | 2004 | 1119 | 0.050 |
Why?
|
| Interferon-gamma | 1 | 2004 | 501 | 0.050 |
Why?
|
| Practice Guidelines as Topic | 2 | 2019 | 1264 | 0.050 |
Why?
|
| Incidence | 1 | 2009 | 3135 | 0.050 |
Why?
|
| Respiratory Tract Infections | 1 | 2004 | 270 | 0.050 |
Why?
|
| Respiratory Syncytial Viruses | 1 | 2001 | 147 | 0.040 |
Why?
|
| Follow-Up Studies | 1 | 2009 | 5130 | 0.040 |
Why?
|
| Visual Acuity | 1 | 2004 | 817 | 0.040 |
Why?
|
| Inservice Training | 1 | 2019 | 55 | 0.040 |
Why?
|
| Prospective Studies | 2 | 2013 | 6116 | 0.040 |
Why?
|
| Advisory Committees | 1 | 2019 | 153 | 0.040 |
Why?
|
| Patient Transfer | 1 | 2019 | 104 | 0.040 |
Why?
|
| Influenza, Human | 1 | 2005 | 657 | 0.040 |
Why?
|
| Stakeholder Participation | 1 | 2018 | 24 | 0.040 |
Why?
|
| Retrospective Studies | 4 | 2019 | 16294 | 0.040 |
Why?
|
| Hospitals, Community | 1 | 2018 | 54 | 0.040 |
Why?
|
| Oxygen | 2 | 2015 | 553 | 0.040 |
Why?
|
| Delivery of Health Care | 1 | 2022 | 607 | 0.030 |
Why?
|
| Patient Care Team | 1 | 2019 | 542 | 0.030 |
Why?
|
| Risk Factors | 1 | 2009 | 10243 | 0.030 |
Why?
|
| Demography | 1 | 2015 | 240 | 0.030 |
Why?
|
| Chemokine CCL3 | 2 | 2005 | 15 | 0.030 |
Why?
|
| Chemokine CCL4 | 2 | 2005 | 14 | 0.030 |
Why?
|
| Hospitals, Pediatric | 1 | 2018 | 769 | 0.030 |
Why?
|
| Chemokine CCL2 | 2 | 2005 | 121 | 0.030 |
Why?
|
| Breath Tests | 1 | 2013 | 178 | 0.030 |
Why?
|
| Immunoglobulin M | 1 | 2013 | 212 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2015 | 1031 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2015 | 1252 | 0.020 |
Why?
|
| Bacteria | 1 | 2015 | 484 | 0.020 |
Why?
|
| Meningitis, Bacterial | 1 | 2011 | 93 | 0.020 |
Why?
|
| Logistic Models | 1 | 2015 | 1800 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2013 | 776 | 0.020 |
Why?
|
| Sex Factors | 1 | 2013 | 1278 | 0.020 |
Why?
|
| Caregivers | 1 | 2013 | 556 | 0.020 |
Why?
|
| Bacteremia | 1 | 2011 | 405 | 0.020 |
Why?
|
| Urinary Tract Infections | 1 | 2011 | 301 | 0.020 |
Why?
|
| Chemokine CCL5 | 1 | 2005 | 53 | 0.010 |
Why?
|
| Exudates and Transudates | 1 | 2004 | 20 | 0.010 |
Why?
|
| Adult | 1 | 2004 | 29367 | 0.010 |
Why?
|
| Surveys and Questionnaires | 1 | 2013 | 3688 | 0.010 |
Why?
|
| Respiratory Syncytial Virus, Human | 1 | 2004 | 204 | 0.010 |
Why?
|
| Nasopharynx | 1 | 2001 | 79 | 0.010 |
Why?
|
| Th2 Cells | 1 | 2001 | 185 | 0.010 |
Why?
|
| Th1 Cells | 1 | 2001 | 153 | 0.010 |
Why?
|
| Cytokines | 1 | 2001 | 1289 | 0.010 |
Why?
|